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Neuropsychological methods in 
mild cognitive impairment
Mild cognitive impairment (MCI) is a concept that was
introduced by Flicker et al
1 and the Mayo Clinic group
2,3
to fill the gap between cognitive changes associated with
normal aging and those associated with dementia.The
concept of MCI draws attention to cognitive distur-
bances that occur before the clinical diagnosis of demen-
tia.The cognitive changes, measured by neuropsycho-
logical test scores,indicate deviation from normal aging
and do not involve loss of autonomy.Nevertheless,these
MCI criteria are not fully specified or generally agreed
upon.As a consequence, studies of MCI conducted by
different research groups have divergent results (eg,the
number of patients with MCI who develop frank demen-
tia of the Alzheimer’s type in follow-up studies).
3-5
Heterogeneity of the MCI population
In 2001,an international group of experts suggested the
subdivision of MCI into three subcategories
6:
• Amnestic MCI, characterized by memory complaint,
preservation of activities of daily living,and objective
and isolated memory impairment (compared with age
and education norms).
• Multiple cognitive domain MCI,characterized by mul-
tiple areas of cognitive impairment (without associated
memory deficit) not sufficiently severe to constitute
dementia.
• Single cognitive domain (other than memory) MCI,
characterized by a deficit of a specific domain as apha-
sia or executive dysfunction reflecting prodromal pri-
mary progressive aphasia or frontotemporal dementia.
In order to limit the heterogeneity of the population
concerned by MCI, it will soon be possible to identify
the underlying pathological disorders before the affected
patients meet the criteria of dementia (Table I), using
specific neuropsychological assessments and, in some
cases,neuroimaging.This is the case,for example,for the
following:
• Frontotemporal degeneration can be identified well
before the stage of clinical dementia in the presence of
apathy and/or behavioral disinhibition coupled with a
progressive disturbance in executive functions.
• Primary progressive aphasia can be identified early on
the basis of anomia with speech apraxia and phonetic
disintegration associated with limited atrophy of left
perisylvian region.
Copyright © 2004 LLS SAS. All rights reserved
The concept of mild cognitive impairment (MCI) was introduced to fill the gap between cogni-
tive changes associated with normal aging and those associated with dementia. Such cognitive
changes indicate a deviation from normal aging, but are insufficient to evoke dementia and do
not indicate loss of autonomy. MCI is thus a transitional state before dementia. MCI covers a
range of disorders and raises the question of population heterogeneity; three MCI subcategories
have been defined to reduce this heterogeneity. Recognizing MCI is only a first step; for a given
patient, it is more important to try to identify the disease responsible, which is now possible using
neuropsychology and neuroimaging. Here, we introduce the concept of “prodromal stage” for
various degenerative diseases, and propose replacement of the amnestic MCI subcategory with
“prodromal Alzheimer’s disease,” for which we present the neuropsychological characteristics.• Diffuse Lewy body disease is characterized by early-
onset hallucinations, cognitive fluctuations, and
extrapyramidal signs, often appearing before the
development of clinical dementia.
• The cerebrovascular origin of cognitive disorders can
be easily recognized at the early stages with appropri-
ate combination of clinical history,neurological exam-
ination,and neuroimaging.
• Alzheimer’s disease (AD) can also be identified at a
prodromal stage.
Amnestic MCI or “prodromal AD”
We would like to discuss the subcategory of amnestic
MCI and introduce the concept of “prodromal
AD”(Table II).
6-9AD patients constitute the most impor-
tant subgroup of patients with MCI, and can be identi-
fied before appearance of fully developed clinical
dementia. Indeed, long before the onset of clinical
dementia,AD is already at work on the brain,following
a rather predictable route. Neuropathological changes
are present in mesial temporal regions (hippocampal
formations,parahippocampal gyrus,and entorhinal cor-
tex), which are critical regions for long-term episodic
memory. AD can be recognized as an “amnestic syn-
drome of the hippocampal type”long before the appear-
ance of other cognitive disturbances.
The presence of AD in its earliest, predementia stages,
may be detectable by use of specific memory tests aimed
at distinguishing the characteristic pattern of memory
disorders associated with the disease.In order to distin-
guish the amnestic syndrome of prodromal AD from
other memory disorders encountered in the aged popu-
lation (encoding deficits due to depression, impaired
retrieval of information, etc), it is necessary to find evi-
dence for the specific storage deficit that characterizes
AD.For that purpose,it is particularly important to use
a memory test that isolates the storage stage.
The procedure of the Free and Cued Selective
Reminding test
10,11 allows an accurate analysis of deficit
by distinguishing the encoding, retrieval, and storage
processes (Figure 1). In this task, the 16 items to be
learned are presented to the patient on four different
cards, one card with four items at a time. None of the
items is a prototype of its category.The patient is asked
to point to and read aloud each item (eg, grapes) in
response to its category cue (eg, fruit).When all four
items of a card are correctly named,the card is removed
and immediate verbal cued recall is assessed, in the
order of identification, by providing each category cue
(eg, what was the fruit?).Whenever a patient is unable
to recall an item in response to its cue,the procedure of
pointing and naming is performed again.Once immedi-
ate cued recall for a group of four items on one card is
completed, the next card is presented. The learning
phase of the 16 items is followed by an intercurrent task
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Figure 1. Specific episodic memory processes.
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to obtain recall from secondary memory.Three succes-
sive recall trials are performed with free recall,and with
cued recall for those items that are not retrieved with
free recall.
This procedure involves a reinforced and controlled
encoding stage, which helps monitor for the attention
deficit or impaired retrieval usually met in normal aging,
and isolates a genuine memory deficit due to a selective
deficit of storage.
A deficit of retrieval is characterized by a low free recall
with a normalization of performance with cueing or
recognition.This pattern is observed in many disorders,
such as depression or executive dysfunction or even in
normal aging. Impaired storage is characterized by a
very low performance in free recall, which is only mar-
ginally improved with cueing.This pattern is observed in
patients with lesions of the hippocampus and related
structures,such as AD.Therefore,before deciding that a
patient has a true amnestic syndrome (ie,putative AD),
it must be established that information has been regis-
tered and cannot be retrieved,even with the use of facil-
itation techniques (no effectiveness of cueing or recog-
nition).
Amnestic syndrome of the hippocampal type
This syndrome is defined by an impaired free recall asso-
ciated with a limited effect of cueing on recall (reflect-
ing storage impairment),together with many intrusions
and false positives on recognition.This profile has been
called amnestic syndrome of the hippocampal type,
11 and
is highly suggestive of AD (provided effective encoding
of information had been checked previously). In con-
trast, it is not encountered in patients with depression,
where encoding deficits are predominant,or in patients
with frontotemporal degeneration, vascular dementia,
or even normal aging, where impaired free recall is
greatly improved or normalized with cueing or recogni-
tion.
12,13 Interestingly, the hippocampal-type memory
profile has also been observed in the early stages of AD,
in patients without dementia (Mini-Mental State
Examination score >25), and in a prospective study of
elderly people who became demented within 5 years.
11,14
This most likely means that episodic memory is a con-
stant, early, and reliable neuropsychological marker of
the disease in relation to early involvement of mesial
temporal structures.
15
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Table I. Differential prodromal dementia.
Diagnosis Clinical criteria (progressive onset of disorder) Neuroimaging: location of atrophy
Primary progressive aphasia - Anomia Left perisylvian
(PPA) - Speech apraxia
- Phonetic disintegration
Frontotemporal degeneration - Behavioral disorders: apathy or disinhibition Frontal
(FTD) - Executive dysfunction
Diffuse Lewy body disease - Early hallucinations Mesial temporal
(DLB) - Cognitive fluctuations Parieto-occipital
- Extrapyramidal signs
Table II. Diagnostic criteria for “prodromal AD.”
Reproduced from reference 8: Dubois B, Albert ML. Amnestic MCI or prodromal Alzheimer’s disease? Lancet Neurol. 2004;3:246-248. Copyright © 2004. Elsevier.
Diagnosis Clinical criteria (progressive onset of disorder) Neuroimaging: location of atrophy
“Prodromal AD” or  - Memory complaints by the patient and by the family Hippocampal
“MCI of the Alzheimer type” - Normal activities of daily living or mildly impaired 
complex activities
- Amnestic syndrome of the “hippocampal type” defined by:
• Deficit of free recall, despite controlled encoding
• Ineffective effect of cueing or impaired recognition
• Numerous intrusions399
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It appears to be possible to identify patients with prodromal AD, even today, using specific neu-
ropsychological tools that demonstrate an amnestic syndrome of the hippocampal type.
8 Once
this hippocampal amnesia has been found, neuropsychological testing should seek normal per-
formance in other cognitive domains, such as language, praxia, gnosia, and executive functions.
Subtle deficits of executive functions such as working memory and verbal fluency impairment
can be observed at this stage.
We believe that the diagnosis of the predementia stage of AD will soon benefit from the combi-
nation of neuropsychology and structural and functional neuroimaging, focused on the hip-
pocampal formations and related structures.
16,17 We propose clinical diagnostic criteria with high
specificity for MCI of the Alzheimer type or prodromal AD.This may help clinicians to identify
the largest subgroup of patients with MCI.